Literature DB >> 12409861

Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression.

Shumel Fennig1, Amos Mottes, Gal Ricter-Levin, Ilan Treves, Yechiel Levkovitz.   

Abstract

This study was designed to compare neuropsychological memory measures ("laboratory memory tests") and an everyday memory measure in patients with schizophrenia, patients with major depression, and normal controls. Patients with schizophrenia ( N= 68) treated with typical (N = 33) or atypical ( N= 35) neuroleptics, patients with major depression (N = 30), and a control group (N = 36) were evaluated with clinical measures (Positive and Negative Syndrome Scale and Hamilton Depression Rating Scale), laboratory memory tests (Digit-Span, Paired-Associates, Rey Complex Figure Test, and Digit-Symbol), everyday memory test (RMBT), and the Global Assessment of Functioning (GAF). The schizophrenia group had a significantly lower level of performance in everyday memory and general function but not in laboratory memory tests. Verbal and everyday memory measures were correlated with general function. The diagnosis rather than current symptoms (in remission) contributed to test variance and was correlated with performance on everyday memory and general function tests. Everyday memory and verbal memory were good predictors of general function in schizophrenic and depressive patients in the remitted phase. However, the advantages of these tests over laboratory memory tests need to be further investigated in larger and more representative samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409861     DOI: 10.1097/00005053-200210000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Robert N Faull
Journal:  J Nerv Ment Dis       Date:  2013-09       Impact factor: 2.254

3.  Everyday memory errors in older adults.

Authors:  Lynn Ossher; Kristin E Flegal; Cindy Lustig
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2012-06-13

4.  Neuropsychological performance in partly remitted unipolar depressive patients: focus on executive functioning.

Authors:  Jens Westheide; Michael Wagner; Boris B Quednow; Christian Hoppe; Déirdre Cooper-Mahkorn; Birgitta Strater; Wolfgang Maier; Kai-Uwe Kuhn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

Review 5.  A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder.

Authors:  C Woolf; A Lampit; Z Shahnawaz; J Sabates; L M Norrie; D Burke; S L Naismith; L Mowszowski
Journal:  Neuropsychol Rev       Date:  2021-04-28       Impact factor: 7.444

6.  Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients.

Authors:  Dongping Rao; Guiyun Xu; Zenghong Lu; Huiwei Liang; Kangguang Lin; Muni Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-09       Impact factor: 2.570

7.  Performance on the Wechsler Adult Intelligence Scale (WAIS) in Japanese patients with bipolar and major depressive disorders in euthymic and depressed states.

Authors:  Junko Matsuo; Hiroaki Hori; Ikki Ishida; Moeko Hiraishi; Miho Ota; Shinsuke Hidese; Yukihito Yomogida; Hiroshi Kunugi
Journal:  Psychiatry Clin Neurosci       Date:  2021-02-10       Impact factor: 5.188

8.  Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.

Authors:  Young Sup Woo; Joshua D Rosenblat; Ron Kakar; Won-Myong Bahk; Roger S McIntyre
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-02-29       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.